• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 11775685216
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/13/2014
Event Type  malfunction  
Event Description
The customer received questionable creatinine plus results for an unknown number of patient samples from three analytical p module analyzers at the site.Data was provided for three patient samples.Only the serial number for one analyzer, (b)(4) was provided.Patient sample 1 initial result was 243 umol/l and was reported outside the laboratory.The result was questioned and the patient was redrawn on (b)(6) 2014 with a result of 76 umol/l.The first sample was then repeated and the result was 74 umol/l.The patient was suspected to have kidney disease and was investigated for renal impairment, but was not adversely affected.The date of testing for the following samples was not provided.Patient sample 2 initial result was 330 umol/l and the repeat result was 75 umol/l.Patient sample 3 initial result was 154 umol/l and the repeat result was 81 umol/l.Information concerning which of these results was reported outside the laboratory or if the patients were adversely affected was requested, but was not provided.The creatinine r1 reagent lot number was 602987.The expiration date was requested, but was not provided.Review of the reaction monitor for one sample indicated something happened to the reaction when the r2 reagent was added indicating a possible reagent needle carryover from the r2 reagent.
 
Manufacturer Narrative
This event occurred in (b)(6).
 
Manufacturer Narrative
A specific root cause could not be identified.The maintenance status of the analyzer and preanalytical procedures were found to be the main factors influencing the jump in the reaction after r2 reagent addition.Intensive maintenance was performed including replacement of the sample probes, reagent probes and gear pump.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS
Type of Device
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 6830 5
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key4305541
MDR Text Key5081391
Report Number1823260-2014-09685
Device Sequence Number1
Product Code JFY
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
K953239
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 01/22/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/08/2014
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number11775685216
Device Lot Number606111
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Event Location Laboratory
Date Manufacturer Received11/14/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ALENDRONINEZUUR; CALCI-CHEW 500/800; PREDNISONE; PANTAPROZOL
Patient Age033 YR
-
-